Takeda Pharmaceutical (TAK) Divestments (2018 - 2026)

Takeda Pharmaceutical's Divestments history runs 9 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• In Q1 2026, Divestments fell 95.43% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $228.7 million (up 69.16% YoY), while the FY2026 annual figure was $221.4 million, up 64.05% from the prior year.
• Divestments was $3.3 million for Q1 2026 at Takeda Pharmaceutical, down from $20.6 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $224.2 million in Q1 2022 to a low of -$48471.0 in Q3 2023.
• Historically, Divestments has averaged $60.2 million across 5 years, with a median of $19.7 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Divestments jumped 74636.55% in 2024, then slumped 95.43% in 2026.
• A 5-year view of Divestments shows it stood at $224.2 million in 2022, then slumped by 100.02% to -$48471.0 in 2023, then surged by 17198.88% to $8.3 million in 2024, then surged by 148.14% to $20.6 million in 2025, then plunged by 84.03% to $3.3 million in 2026.
• The last three Divestments figures came in at $3.3 million (Q1 2026), $20.6 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.